Skip to content

A Pilot Randomized Control Trial to Help Youth Smokers to Quit Smoking:

Effectiveness of Using Adventure-based Training and WhatsApp Group to Relieve Emotion and Pressure so as to Quit Smoking: A Pilot Randomized Control Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03021655
Enrollment
300
Registered
2017-01-16
Start date
2016-12-31
Completion date
2022-01-31
Last updated
2020-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation

Keywords

Youth, Randomized controlled trial, Adventure-based training, WhatsApp

Brief summary

This study is a 3-arm randomized controlled trial including: (1) Adventure-based training intervention group, (2) WhatsApp intervention group and (3) Control group.

Detailed description

Depression and stress are obstacles of youth smokers to quit smoking, youth smokers who have positive thinking and less depression exhibited smoking abstinence at last. Adventure-based training could enhance participants' self-efficacy, self-esteem and also improve mental health of children and youth by doing physical activity. On the other hand, previous mobile phone-based studies (e.g. short messaging services or Apps) showed that the mental health of youth had been improved by providing instant response to the subjects when they felt depressed. A paper published recently proved that WhatsApp group could prevent relapse among the quitters. Thus, adventure-based training and social support in WhatsApp group would predict to reduce depression and stress so as to quit smoking in youth.

Interventions

BEHAVIORALAdventure-based intervention group

One-day adventure-based training will be assigned to subjects and the activities include wall climbing, rope course and health talk on mood, pressure management and smoking cessation.

BEHAVIORALWhatsApp intervention group

A WhatsApp group will be opened for the subjects and we will send messages about mood and pressure management to them and encourage them to quit smoking. The subjects can share their unhappy things in the group.

BEHAVIORALControl group

Telephone follow-up will be conducted at 1-week, 1-, 3-, 6-, 9-, 12-, 24-month and smoking cessation counselling will be delivered to the subjects.

Sponsors

The University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to 25 Years
Healthy volunteers
No

Inclusion criteria

* Hong Kong resident aged 25 or below * Able to communicate, read and write in Cantonese/ Chinese * Smoked in the past 30 days * Mobile can access internet * Would access internet through mobile or at home

Exclusion criteria

* Have difficulty to communicate via telephone * Ever used/using psychiatric drugs * Physically disabled * Having queries irrelevant to tobacco control * Undergoing other smoking cessation service

Design outcomes

Primary

MeasureTime frameDescription
Self-reported 7-day point prevalence6-monthThe subjects will be asked whether they have smoked cigarette in the past 7 day at 6-month

Secondary

MeasureTime frameDescription
Biochemical validated quit rate6-monthBio-chemical validated quit rate will be conducted if the subjects who reported they have been stop smoking for at least 7 days at 6-month. They will be invited to perform saliva cotinine test (using NicAlert strip) plus exhaled carbon monoxide text to validate the smoking status.
Change in Depressive symptoms6-monthA 20-item scale (CESDC) will be used to assess the depressive symptoms of the subjects after 6 months.
Change in Self-esteem6-monthA 10-item scale (RSES) will be used to assess the self-esteem level of the subjects after 6 months.
Change in Quality of life6-monthA 11-item scale (SF-6D) will be used to assess the quality of life of the subjects after 6 months.

Countries

China

Contacts

Primary ContactHo-cheung Li, PhD
william3@hku.hk39176634

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026